The predictive value of the systemic immune-inflammatory index for left atrial appendage thrombus in non-valvular

Fatih Koca1, Fatih Levent1, Baris Sensoy1

  • 1Bursa Education and Research Hospital, University of Health Sciences, Bursa, Turkey.

Insights

The systemic immune inflammatory index (SII) can predict left atrial appendage (LAA) thrombus in non-valvular atrial fibrillation patients. This accessible test aids in determining anticoagulant therapy decisions.

Area of Science:

  • Cardiology
  • Hematology
  • Inflammation Research

Background:

  • The systemic immune inflammatory index (SII) is recognized for its prognostic capabilities in cardiovascular diseases.
  • Non-valvular atrial fibrillation (NVAF) poses a significant risk for thromboembolic events, particularly left atrial appendage (LAA) thrombus formation.

Purpose of the Study:

  • To evaluate the predictive value of the SII for the presence of LAA thrombus in patients diagnosed with NVAF.
  • To determine if SII can serve as a biomarker for guiding anticoagulant treatment decisions in this patient cohort.

Main Methods:

  • A cohort of 525 patients with newly diagnosed NVAF, treatment-naïve for anticoagulation, were included.
  • Transesophageal echocardiography was performed on all participants to assess for LAA thrombus.
  • Multivariate regression analysis and ROC curve analysis were employed to identify predictors of LAA thrombus.

Main Results:

  • Left atrial appendage thrombus was identified in 16.4% of the study population.
  • The SII demonstrated significant diagnostic power for LAA thrombus (AUC: 0.760, P<0.001).
  • Independent predictors for LAA thrombus included diabetes, LAA emptying rate <20 cm/s, and an SII value >750 (all P<0.05).

Conclusions:

  • The SII is a practical and readily available marker that effectively predicts LAA thrombus in patients with NVAF.
  • The findings suggest that SII can be a valuable tool in clinical decision-making regarding anticoagulant therapy for NVAF patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
43
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
410